Johnson & Johnson
JNJ60
$149.04arrow_drop_down0.37%-$0.56
S&P500
JNJ60
$149.04
arrow_drop_down0.37%Performance History
| Key Stats | |
|---|---|
| Open | $149.93 |
| Prev. Close | $149.60 |
| EPS | 6.05 |
| Next Earnings Date | Mar 11, 2025 |
| LOW | HIGH | |
|---|---|---|
| Day Range | 148.39 | 150.55 |
| 52 Week Range | 143.13 | 168.85 |
| Ratios | |
|---|---|
| EPS | 6.05 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About Johnson & Johnson (JNJ)
- Sector
- Healthcare
- Industry
- Drug Manufacturers—General
- CEO
- Mr. Joaquin Duato
- Headquarters
- New Brunswick
- Employees
- 152700
- Exchange
- NYSE
Keep an eye on Johnson & Johnson
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Johnson & Johnson's (JNJ) price per share?
The current price per share for Johnson & Johnson (JNJ) is $149.04. The stock has seen a price change of -$0.56 recently, indicating a -0.37% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Johnson & Johnson (JNJ)?
For Johnson & Johnson (JNJ), the 52-week high is $168.85, which is 13.29% from the current price. The 52-week low is $143.13, the current price is 4.13% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Johnson & Johnson (JNJ) a growth stock?
Johnson & Johnson (JNJ) has shown an average price growth of -2.59% over the past three years. It has received a score of 38 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Johnson & Johnson as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Johnson & Johnson (JNJ) stock price performance year to date (YTD)?
As of the latest data, Johnson & Johnson (JNJ) has a year-to-date price change of -6.83%. Over the past month, the stock has experienced a price change of -3.87%. Over the last three months, the change has been -10.54%. Over the past six months, the figure is 1.3%. Looking at a longer horizon, the five-year price change stands at 6.08%.
help
Is Johnson & Johnson (JNJ) a profitable company?
Johnson & Johnson (JNJ) has a net income of $13.33B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 68.59% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 24.52% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $85.16B, with a revenue growth rate of 6.46%, providing insight into the company's sales performance and growth. The gross profit is $58.41B. Operating income is noted at $21.85B. Furthermore, the EBITDA is $32.78B.
help
What is the market capitalization of Johnson & Johnson (JNJ)?
Johnson & Johnson (JNJ) has a market capitalization of $359.89B. The average daily trading volume is 149.44, indicating the stock's liquidity and investor engagement.